| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |